TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TBPH

Theravance Biopharma Inc

Healthcare · Biotechnology

17.00$ +0.1% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Theravance Biopharma Inc (TBPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 470 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TBPH
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
356 639 588 544 486 441 480 421 371 560 531 492 445 409 605 564 512 469 375 429 403 375 355 361 763 607 539 447 414 382 371 362 356 354 344 426 415 486 472 470
274 529 422 385 367 379 447 387 333 533 467 426 356 338 534 498 451 393 293 333 297 250 205 155 512 353 261 192 162 134 124 119 116 161 150 366 355 418 418 417
87 345 170 140 91 89 126 104 101 378 223 178 102 58 333 105 93 81 114 205 121 90 94 87 419 298 188 106 72 40 54 46 23 38 111 282 175 168 288 220
230 501 393 362 335 349 419 353 300 505 434 396 320 281 487 438 358 293 210 265 216 173 148 133 487 327 241 167 134 102 100 96 91 88 131 339 330 315 395 388
24 9.1 8.9 5.3 12 7.1 4.8 3.9 6.9 11 7.9 0.1 9.3 51 42 47 61 70 12 40 14 58 12 12 14 17 12 16 17 17 15 14 17 68 15 22 18 96 16 20
12 12 13 12 15 17 17 18 18 0.0 0.0 – 7.5 0.0 – – 21 20 19 16 13 10 0.0 – -68 1.5 1.5 1.0 1.6 0.0 – – -17 – – – – – – –
8.8 8.5 8.3 8.7 8.6 10 10 11 12 13 13 13 12 13 14 14 15 16 17 17 57 53 13 54 12 12 12 9.6 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
58 289 294 303 302 326 417 387 384 612 645 630 628 633 763 767 774 773 748 730 727 713 707 711 283 166 168 166 167 169 166 168 170 179 178 201 183 189 182 180
45 49 49 57 49 63 105 93 102 99 114 110 109 112 98 107 104 124 86 67 66 59 44 33 142 29 26 25 25 25 22 23 23 32 32 55 37 38 32 31
223 223 223 223 223 224 224 224 – – 8.3 20 16 18 8.0 8.7 9.7 29 13 8.0 14 17 13 2.6 0.7 6.8 7.4 9.2 9.7 3.9 4.1 4.2 4.2 11 11 11 11 11 11 11
5.4 1.7 3.6 6.4 5.6 5.9 5.1 3.6 3.7 9.0 5.6 3.5 8.7 4.8 6.6 10 6.4 6.8 6.8 11 8.9 3.1 1.5 3.1 5.3 1.6 2.7 1.6 2.4 1.5 1.7 1.7 1.5 2.2 2.4 1.7 2.2 2.6 1.1 0.7
0.0 223 223 223 223 224 224 224 225 454 446 443 448 445 226 226 227 227 227 227 603 599 228 625 – – – – – – – – – – – – – – – –
298 350 294 241 184 115 63 34 -13 -52 -113 -137 -183 -224 -158 -202 -262 -304 -373 -300 -324 -339 -351 -350 481 442 371 280 246 213 205 194 186 176 166 225 233 297 291 290
-445 -512 -578 -644 -711 -798 -862 -903 -962 -1,012 -1,085 -1,125 -1,183 -1,249 -1,332 -1,395 -1,468 -1,527 -1,606 -1,659 -1,694 -1,726 -1,752 -1,760 -844 -854 -876 -892 -901 -909 -921 -937 -950 -966 -979 -924 -921 -860 -865 -870
46 50 52 52 53 53 53 54 54 55 55 56 56 56 59 63 63 64 64 66 74 74 75 76 76 67 63 57 52 49 48 49 49 49 50 51 52 53 51 52

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?